🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/03/2016 50,69 50,85 50,24 50,41 -0,45% 1,20% 6.337.046
24/03/2016 50,37 50,91 50,18 50,64 -0,02% 1,44% 7.929.378
23/03/2016 51,15 51,15 50,43 50,65 +0,09% 1,40% 10.424.980
22/03/2016 50,17 51,01 50,14 50,60 +0,44% 1,73% 9.748.810
21/03/2016 49,93 50,41 49,71 50,38 +1,05% 1,40% 8.014.161
18/03/2016 49,37 50,02 49,23 49,86 +1,40% 1,60% 15.116.666
17/03/2016 49,55 49,59 48,98 49,17 -0,79% 1,23% 10.038.163
16/03/2016 49,91 49,91 49,20 49,56 -0,92% 1,43% 10.460.402
15/03/2016 50,08 50,23 49,57 50,02 -1,24% 1,31% 9.495.614
14/03/2016 50,72 50,88 50,42 50,65 -0,23% 0,90% 6.846.479
11/03/2016 50,59 51,01 50,36 50,76 +0,30% 1,28% 16.277.955
10/03/2016 50,28 50,80 50,03 50,61 +1,30% 1,54% 12.856.340
09/03/2016 50,17 50,47 49,71 49,96 -0,17% 1,50% 9.589.829
08/03/2016 49,96 50,51 49,90 50,05 -0,36% 1,22% 8.665.912
07/03/2016 49,47 50,51 49,38 50,23 +1,08% 2,28% 7.824.682
04/03/2016 49,48 49,90 49,14 49,69 -0,04% 1,52% 9.521.918
03/03/2016 49,79 49,92 48,81 49,71 -0,33% 2,24% 10.279.622
02/03/2016 49,27 50,04 49,16 49,88 +1,00% 1,78% 12.548.857
01/03/2016 48,08 49,56 47,80 49,38 +3,07% 3,67% 12.686.774
29/02/2016 48,21 48,50 47,85 47,91 -0,85% 1,35% 13.507.358
26/02/2016 48,71 48,79 48,31 48,32 -0,71% 0,98% 9.695.362
25/02/2016 48,24 48,66 48,08 48,66 +0,87% 1,21% 9.110.998
24/02/2016 47,86 48,30 47,36 48,24 +0,04% 1,97% 7.936.190
23/02/2016 48,24 48,61 48,12 48,23 -0,45% 1,01% 8.278.676
22/02/2016 47,98 48,45 47,83 48,44 +1,30% 1,29% 8.143.274
19/02/2016 47,95 48,09 47,59 47,82 -0,40% 1,05% 9.394.482
18/02/2016 48,28 48,65 47,95 48,02 -0,55% 1,46% 10.074.319
17/02/2016 47,71 48,33 47,67 48,28 +1,65% 1,38% 9.770.818
16/02/2016 47,14 47,70 46,98 47,50 +1,53% 1,52% 11.964.178
12/02/2016 46,74 46,86 46,07 46,78 +0,37% 1,69% 14.251.018